InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Shiferman Gregory L.. Director active across 2 companies, notably Sage Therapeutics, Inc.. Aggregated, 10 disclosures have been recorded. History available since 1 November 2024. The latest transaction was filed on 1 April 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations
Shiferman Gregory L. has 10 filings in total. In the 10 most recent sampled filings, covering the period from 2024-11-01 to 2026-04-03, both buy and sell amounts are 0 EUR, and the most frequent transaction nature is Tax withholding. The recent filings concern Sage Therapeutics, Inc. and Voyager Therapeutics, Inc., with amounts including 17890.49678821894 EUR, 2597.847903044819 EUR, 627.2517368794513 EUR, 598.5642713155645 EUR, 416.0361477734091 EUR, and 0 EUR.